ENSURE PLUS ADVANCE PŘÍCHUŤ VANILKA

Základní informace

  • Název přípravku:
  • ENSURE PLUS ADVANCE PŘÍCHUŤ VANILKA Perorální roztok
  • Léková forma:
  • Perorální roztok
  • Podání:
  • Perorální podání
  • Jednotky v balení:
  • 30X220ML Krabička
  • Použij pro:
  • Lidé
  • Léčitelství typu:
  • alopatický drog

Dokumenty

Lokalizace

  • K dispozici v:
  • ENSURE PLUS ADVANCE PŘÍCHUŤ VANILKA Perorální roztok
    Česká republika
  • Jazyk:
  • čeština

Terapeutická informace

  • Terapeutické oblasti:
  • POTRAVINY PRO ZVLÁŠTNÍ LÉKAŘSKÉ ÚČELY (PZLÚ)
  • Přehled produktů:
  • ENSURE PLUS ADVANCE PŘÍCHUŤ VANILKA

Další informace

Stav

  • Zdroj:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Poslední aktualizace:
  • 22-06-2017

Příbalovou informaci pro pacienta

1.


Vanilková příchuť


ENSURE PLUS ADVANCE


1,g CaHMB 330kcal 20g Bílkovin 13mcg Vítamínu D


Potravina pro zvláštní lékařské účely


e 220 ml


2.

Určeno k dietnímu postupu při podvýživě nebo nutričně ohrožených starších jedinců.

Ensure Plus Advance je vysoce kalorická, kompletní a vyvážená perorální výživa bohatá na bílkoviny a vitamín D s obsahem FOS a Ca-HMB.

NÁVOD K POUŽITÍ: Určeno k přímé spotřebě jako tekutá strava (nápoj). PŘED OTEVŘENÍM DOBŘE PROTŘEPEJTE. Po otevření výrobek uzavřete, uchovávejte v chladničce a spotřebujte do 24 hodin. Neotevřenou výživu uchovávejte při pokojové teplotě.

DŮLEŽITÉ UPOZORNĚNÍ: Ensure Plus Advance je doplňkový zdroj výživy. Používejte na základě doporučení lékaře nebo osoby kvalifikované v oblasti výživy lidí, farmacie nebo péče o matku a dítě. Není určeno pro děti, pokud to nedoporučí lékař nebo osoba kvalifikovaná v oblasti výživy. Neužívat při galaktosémii. Není určeno k parenterálnímu použití. Bez lepku.

Doporučené dávkování: 2 balení denně


Složení: voda, hydrolyzovaný kukuřičný škrob, mléčné bílkoviny, sacharóza, rostlinný olej (řepkový, kukuřičný), izolovaná sójová bílkovina, minerály (citronan draselný, citronan sodný, fosforečnan vápenatý, uhličitan hořečnatý, chlorid draselný, síran železnatý, síran zinečnatý, síran manganatý, síran měďnatý, molybdenan sodný, jodid draselný, chlorid chromitý a selenan sodný), FOS, Ca-HMB, aroma, emulgátor: sójový lecitin, stabilizátory (E 460, E 466, E 418), cholin-chlorid, VITAMÍNY ( C, E, nikotinamid, pantothenan vápenatý, beta karoten, B6, B1, B2, vit. A palmitát,kyselina listová, K1, D3, biotin, B12), L-karnitin.


Vyrobeno v EU.


CZ: Abbott Laboratories s.r.o., Hadovka Office Park, Evropská 2591/33d

160 00 Praha 6, Česká republika




Osmolarita 557 mOsm/l


EAN- 8710428002358 160-392-00 S558



Nutriční informace




ve 100 ml


Energetická hodnota

kcal

150


kJ

631

Bílkoviny/Bielkoviny

g

9,10

Tuky

g

4,80

z toho nasycené/nasýtené

g

0,42

Sacharidy

g

16,80

z toho cukry

g

6,8

FOS

g

0,75

HMB

g

0,55

Voda

g

76,50

Karnitin/Karnitín

mg

18

Vitamíny



Vitamín A (palmitan/ palmitát)

µg RE

60

Vitamín A (betakaroten/ betakarotén)

µg RE

60

Vitamín D3

µg

5,7

Vitamín E

mg α-TE

2,5

Vitamín K1

µg

15

Vitamín C

mg

16

Kyselina listová

µg

35

Thiamin/Tiamín (vitamín B1)

mg

0,26

Riboflavin/Riboflavín (vitamín B2)

mg

0,34

Vitamín B6

mg

0,734

Vitamín B12

µg

0,65

Niacin/Niacín

mg NE

3,0

Kyselina pantothenová/pantoténová

mg

1,1

Biotin/Biotín

µg

6,0

Cholin/Cholín

mg

70

Minerály



Sodík

mg

160

Draslík

mg

270

Chlór

mg

139

Vápník/Vápnik

mg

227

Fosfor

mg

120

Hořčík/Horčík

mg

25

Železo

mg

2,1

Zinek/Zinok

mg

1,75

Mangan/Mangán

mg

0,45

Měď/Meď

µg

245

Jód

µg

22

Selen/Selén

µg

8,5

Chrom/Chróm

µg

10

Molybden/Molybdén

µg

15


Nutriční informace




ve 100 ml


Energetická hodnota

kcal

150


kJ

631

Bílkoviny/Bielkoviny

g

9,10

Tuky

g

4,80

z toho nasycené/nasýtené

g

0,42

Sacharidy

g

16,80

z toho cukry

g

6,8

FOS

g

0,75

HMB

g

0,55

Voda

g

76,50

Karnitin/Karnitín

mg

18

Vitamíny



Vitamín A (palmitan/ palmitát)

µg RE

60

Vitamín A (betakaroten/ betakarotén)

µg RE

60

Vitamín D3

µg

5,7

Vitamín E

mg α-TE

2,5

Vitamín K1

µg

15

Vitamín C

mg

16

Kyselina listová

µg

35

Thiamin/Tiamín (vitamín B1)

mg

0,26

Riboflavin/Riboflavín (vitamín B2)

mg

0,34

Vitamín B6

mg

0,734

Vitamín B12

µg

0,65

Niacin/Niacín

mg NE

3,0

Kyselina pantothenová/pantoténová

mg

1,1

Biotin/Biotín

µg

6,0

Cholin/Cholín

mg

70

Minerály



Sodík

mg

160

Draslík

mg

270

Chlór

mg

139

Vápník/Vápnik

mg

227

Fosfor

mg

120

Hořčík/Horčík

mg

25

Železo

mg

2,1

Zinek/Zinok

mg

1,75

Mangan/Mangán

mg

0,45

Měď/Meď

µg

245

Jód

µg

22

Selen/Selén

µg

8,5

Chrom/Chróm

µg

10

Molybden/Molybdén

µg

15















































17-7-2018

ALDI Voluntarily Recalls AnnaSea Wasabi Ahi Poke Hawaiian Poke Kits and Limu Ahi Poke Hawaiian Poke Kits Due to Storage at Incorrect Temperature in Area Store

ALDI Voluntarily Recalls AnnaSea Wasabi Ahi Poke Hawaiian Poke Kits and Limu Ahi Poke Hawaiian Poke Kits Due to Storage at Incorrect Temperature in Area Store

Batavia, Ill. Uuly 14, 2018) -ALDI has voluntarily recalled AnnaSea Wasabi Ahi Poke Hawaiian Poke Kits and Limu Ahi Poke Hawaiian Poke Kits sold at one retail store location in North Carolina. While the products are required to remain at frozen temperatures to ensure safety, this store location displayed and sold the products from the cooler section. Because storing the products at temperatures above freezing prior to consumption can render the products unsafe for consumption, ALDI is recalling these items.

FDA - U.S. Food and Drug Administration

12-7-2018

Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

FDA Commissioner Scott Gottlieb, M.D., on new drug shortages task force and work towards long-term solutions to prevent shortages

FDA - U.S. Food and Drug Administration

12-7-2018

FDA expands its support for states to advance implementation of produce safety activities

FDA expands its support for states to advance implementation of produce safety activities

FDA expands its support for states to advance implementation of produce safety activities

FDA - U.S. Food and Drug Administration

11-7-2018

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies, including three disease specific draft guidances

FDA - U.S. Food and Drug Administration

28-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Being able to identify outbreaks is key to being able to take quick action to prevent additional illnesses and find the source of the contamination. In recent years, the FDA and the Centers for Disease Control and Prevention (CDC) have advanced new tools that make it easier and faster to identify outbreaks of human illness and to link them back to the food source that is the culprit responsible for the illnesses. But our improved ability to spot outbreaks has also caused some to question whether we are e...

FDA - U.S. Food and Drug Administration

26-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy

Announcement of public meeting to solicit input on plans to modernize food standards and labeling

FDA - U.S. Food and Drug Administration

12-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

FDA issues draft guidance on collecting patient experiences to inform the development and evaluation of medical products

FDA - U.S. Food and Drug Administration

12-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

FDA - U.S. Food and Drug Administration

5-6-2018

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers by aligning USDA program with FDA’s Produce Safety Rule requirements.

FDA - U.S. Food and Drug Administration

22-5-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

The FDA is announcing three new efforts as part of a comprehensive set of actions to advance the FDA’s framework for sun protection products ahead of this coming summer

FDA - U.S. Food and Drug Administration

17-5-2018

Intent to submit a marketing authorisation application for a veterinary medicinal product using the decentralised procedure with France as a Reference Member State (RMS).

Intent to submit a marketing authorisation application for a veterinary medicinal product using the decentralised procedure with France as a Reference Member State (RMS).

An applicant intending to submit a marketing authorisation application for a veterinary medicinal product using the decentralised procedure with France acting as RMS has to inform the Anses-ANMV at least 2 months in advance.

France - Agence Nationale du Médicament Vétérinaire

15-5-2018

Nonprescription Drugs Advisory Committee

Nonprescription Drugs Advisory Committee

he Nonprescription Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.

FDA - U.S. Food and Drug Administration

2-6-2017

Additional Risk Minimisation Measures (aRMM)

Additional Risk Minimisation Measures (aRMM)

From 1 June 2017 IMA will take seven days to ensure that all relevant documents are enclosed in an application for aRMM evaluation. This is done to facilitate IMAs review of the material.

IMA - Icelandic Medicines Agency

18-12-2006

Reassessment of reimbursement status

Reassessment of reimbursement status

This summer, the Danish Medicines Agency will begin the periodic reassessment of reimbursement status of medicinal products. Over a 5-year period, the reimbursement status of all medicinal products will be reassessed to ensure that the medicinal products having been granted general reimbursement still meet the required criteria and that medicinal products which have not been granted general reimbursement do not meet the criteria.

Danish Medicines Agency

18-7-2018

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a me

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a me

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a medical device.

FDA - U.S. Food and Drug Administration

10-7-2018

News and press releases:  EMA identifies gaps in industry preparedness for Brexit

News and press releases: EMA identifies gaps in industry preparedness for Brexit

Survey indicates that some companies need to step up efforts to ensure medicine supply in the EU

Europe - EMA - European Medicines Agency

5-6-2018

Advance notice - update to an eCTD file download for version 3.1

Advance notice - update to an eCTD file download for version 3.1

The TGA intends to make a small amendment to the eCTD validation criteria

Therapeutic Goods Administration - Australia

29-5-2018

Ensure that you have optimised your Class I medical device ARTG entries

Ensure that you have optimised your Class I medical device ARTG entries

Information sheet to assist sponsors to optimise their Class I ARTG

Therapeutic Goods Administration - Australia

22-5-2018

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens:  http://go.usa.gov/xQmjP 

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens: http://go.usa.gov/xQmjP 

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens: http://go.usa.gov/xQmjP 

FDA - U.S. Food and Drug Administration